Crinetics Pharmaceuticals (CRNX) Competitor Comparison
We are evaluating the key criteria listed to compare Crinetics Pharmaceuticals (CRNX) against its competitors in the Biotechnology industry.
Market Capitalization
66 / 368Gross Profits
245 / 278Total Revenue
201 / 300EBITDA
287 / 337Free Cashflow
281 / 352Quick Ratio
50 / 357Earnings per Share
278 / 359Dividend yield
0 / 6Total Cash
54 / 358Performance 3 years
40 / 368Performance 5 years
45 / 368Performance 10 years
41 / 368Linearity 3 years
345 / 368Linearity 5 years
360 / 368Linearity 10 years
347 / 368Total Rank
95 / 368Dividend Rank
96 / 368Valuation Rank
198 / 368Piotroski Rank
103 / 368Muliplier Rank
319 / 368Earnings per Share - CRNX ranking 278 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.